1. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, et al. ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2011 May 31;123(21):2434-506.
  2. Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2009 Oct 7;(4):CD000028.
  3. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009 Nov;27(11):2121-58.
  4. Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, et al. Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly. Hypertension 2010 Aug 1;56(2):196-202.
  5. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008 Dec;31(12):2115-27.
  6. Mazza A, Ramazzina E, Cuppini S, Armigliato M, Schiavon L, Rossetti C, et al. Antihypertensive Treatment in the Elderly and Very Elderly: Always “the Lower, the Better?”. Int J Hypertens 2012;2012:590683. Epub;%2011 Sep 22.:590683.
  7. Angeli F, Reboldi G, Verdecchia P. “The lower the BP the better” paradigm in the elderly: vanished by VALISH? Hypertension 2010 Aug;56(2):182-4.
  8. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008 May 1;358(18):1887-98.
  9. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001 Sep 29;358(9287):1033–41.
  10. Yusuf S, Diener H-C, Sacco RL, Cotton D, Ounpuu S, Lawton WA, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N. Engl. J. Med. 2008 Sep 18;359(12):1225–37.